CN102994616B - MEK1 gene mutation detection specificity primer and liquid chip thereof - Google Patents
MEK1 gene mutation detection specificity primer and liquid chip thereof Download PDFInfo
- Publication number
- CN102994616B CN102994616B CN201110269701.1A CN201110269701A CN102994616B CN 102994616 B CN102994616 B CN 102994616B CN 201110269701 A CN201110269701 A CN 201110269701A CN 102994616 B CN102994616 B CN 102994616B
- Authority
- CN
- China
- Prior art keywords
- seq
- sequence
- site
- primer
- tag sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention discloses an MEK1 gene mutation detection specificity primer and a liquid chip thereof. The liquid chip mainly comprises: an ASPE primer composed of a 5'-terminal tag sequence and 3'-terminal specificity primer sequences focused on target gene mutation sites, wherein the specificity primer sequences comprise SEQ ID NO.9 and SEQ ID NO.10 focused on a Q56P site, SEQ ID NO.11 and SEQ ID NO.12 focused on a K57N site, SEQ ID NO.13 and SEQ ID NO.14 focused on a D67N site, and/or SEQ ID NO.15 and SEQ ID NO.16 focused on a P124L; a microsphere coated by an anti-tag sequence; and an amplimer. The consistency between the detection result of the detection liquid chip provided by the invention and the detection result of a sequencing method is high to 100%, and the wild-type and mutant parallel detection of a plurality of mutation sites is realized.
Description
Technical field
The invention belongs to biology field, relate to medical science and biotechnology, concrete a kind of MEK1 detection in Gene Mutation Auele Specific Primer and the liquid-phase chip of relating to.
Background technology
MEK1 gene participates in a large amount of vital processes and plays an important role in embryo development procedure, there are some researches show, MEK1 transgenation high frequency appears in tumour, and study hotspot generally concentrates on 4 sites such as Q56P, K57N, D67N and P124L.
At present, the method for MEK1 transgenation being carried out to determination and analysis is little, mainly contains direct sequencing and PCR-RFLP analytical method, and wherein the most frequently used method has PCR-RFLP analytical method.PCR-RFLP method is the change of the restriction enzyme enzyme recognition site that causes based on transgenation, as lost or generation novel site in site, by a certain specific fragment of pcr amplification, use again digestion with restriction enzyme amplified production, the size of electrophoresis observation fragment, the transgenation that this method changes for detection of restriction enzyme site, can directly judge genotype, but this method can not be used for not producing the detection in Gene Mutation of new restriction enzyme site.Again, above these methods all exist the limitation that detects flux, can only detect a kind of mutation type at every turn, can not meet the needs of practical application.
Summary of the invention
One of object of the present invention is to provide MEK1 gene mutation detection liquid-phase chip, and this liquid-phase chip can or be parallel to the wild-type and the saltant type that detect MEK1 gene four kinds of common genotype Q56P, K57N, D67N and P124L with individual event.
A kind of MEK1 gene mutation detection liquid-phase chip, is characterized in that, includes:
(A). the wild-type designing respectively for the different mutational sites of MEK1 gene and the ASPE primer of saltant type: every kind of ASPE primer is made up of for the specific primer sequence in goal gene mutational site tag sequence and the 3 ' end of 5 ' end, and described specific primer sequence is: for SEQ ID NO.9 and the SEQ ID NO.10 in Q56P site; For SEQ ID NO.11 and the SEQ ID NO.12 in K57N site; For SEQ ID NO.13 and the SEQ ID NO.14 in D67N site; And/or for SEQ ID NO.15 and the SEQ ID NO.16 in P124L site; Described tag sequence is selected from SEQ ID NO.1～SEQ ID NO.8;
(B). there is microballoon that anti-tag sequence is coated with, that there is different colours coding, in the middle of described anti-tag sequence is connected with microballoon, be also provided with spacerarm sequence; Described anti-tag sequence is selected from SEQ ID NO.17～SEQ ID NO.24, and described anti-tag sequence can be correspondingly with (A) in selected tag sequence complementary pairing;
(C). for amplifying the primer that needs the target sequence detecting, there is corresponding mutational site.
Preferably, described amplimer is: for SEQ ID NO.25 and the SEQ ID NO.26 in Q56P, K57N, D67N site; And/or for SEQ ID NO.27 and the SEQ ID NO.28 in P124L site.
Preferably, described ASPE primer is: for the sequence being made up of SEQ ID NO.1 and SEQ ID NO.9 in Q56P site and the sequence that is made up of SEQ ID NO.2 and SEQ ID NO.10; For the sequence being formed by SEQ ID NO.3 and SEQ ID NO.11 in K57N site and the sequence that formed by SEQ ID NO.4 and SEQ ID NO.12; For the sequence being formed by SEQ ID NO.5 and SEQ ID NO.13 in D67N site and the sequence that formed by SEQ ID NO.6 and SEQ ID NO.14; And/or for the sequence being formed by SEQ ID NO.7 and SEQ ID NO.15 in P124L site and the sequence that formed by SEQ ID NO.8 and SEQ ID NO.16.
Another object of the present invention is to provide the Auele Specific Primer for MEK1 detection in Gene Mutation.
The technical scheme that realizes above-mentioned purpose is as follows:
For the Auele Specific Primer of MEK1 detection in Gene Mutation, it is: for SEQ ID NO.9 and the SEQ ID NO.10 in Q56P site; For SEQ ID NO.11 and the SEQ ID NO.12 in K57N site; For SEQ ID NO.13 and the SEQ ID NO.14 in D67N site; And/or for SEQ ID NO.15 and the SEQ ID NO.16 in P124L site.
Major advantage of the present invention is:
1. the identical rate of detection method provided by the present invention and sequencing is up to 100%, and detects the needed time well below conventional sequencing technologies, and realistic especially application needs.Prepared MEK1 gene mutation detection liquid-phase chip has extraordinary signal-noise ratio, and between designed probe and anti-tag sequence, substantially there is not cross reaction, choosing and tag sequence label and the specifically combination of ASPE primer of tag sequence label, anti-tag sequence label, can avoid cross reaction, realize the parallel detection in multiple mutational sites.
2. the present invention, by the design experiences of the long-term accumulation of contriver and a large amount of experimental implementation, has chosen optimum combination from numerous Auele Specific Primers.The ASPE primer specificity primer of the present invention design can the sensitive mutational site of identifying specifically target detect, accurately distinguishes the genotype of various types; In same reaction system, between different Auele Specific Primers, substantially there is not cross reaction between Auele Specific Primer and the pcr amplification product of non-target detect, detection specificity is good, and cross reacting rate is lower than 3%; Except detecting Single locus sudden change situation, the also sudden change situation in the multiple mutational sites of parallel detection simultaneously, detects effect consistent.
3. detection method step of the present invention is simple, the amplification that can complete by a step PCR 2 target sequences that contain 4 mutational sites is detected in four kinds of mutational sites, the many uncertain factors that exist in the complex operations processes such as repeated multiple times PCR are avoided, thereby can greatly improve Detection accuracy, embody accurate while qualitative and quantitative analysis feature.
4. not only to have overcome traditional solid phase chip susceptibility not high in the present invention, and the poor defect of repeatability of detected result is improved existing liquid-phase chip technology simultaneously, makes prepared microballoon can be applicable to different test items, has very strong expansion.The fluorescent signal value detecting improves greatly, thereby the sensitivity detecting is further enhanced, and signal to noise ratio strengthens, and detected result more accurately and reliably.
Embodiment
Embodiment 1 MEK1 gene mutation detection liquid-phase chip, mainly includes:
One, ASPE primer
For wild-type and the saltant type of MEK1 gene four kinds of common genotype Q56P, K57N, D67N and P124L, design respectively specific primer sequence.ASPE primer is made up of " tag sequence+specific primer sequence ".ASPE primer sequence is as shown in the table:
The ASPE primer sequence (tag sequence+specific primer sequence) of table 1 MEK1 gene
Every ASPE primer comprises two parts, and 5 ' end is the specificity tag sequence for anti-tag sequence on corresponding microballoon, and 3 ' end is saltant type or the special primer fragment (as shown in Table 1 above) of wild-type.All ASPE primers are synthesized by Shanghai Sangon Biological Engineering Technology And Service Co., Ltd.Every primer after synthetic is mixed with respectively the stock solution of 100pmol/mL with 10mmol/L Tris Buffer.
Two, the coated microballoon of anti-tag sequence
According to designed ASPE Auele Specific Primer fragment, select tag sequence, reduce to greatest extent between the anti-tag sequence of each microballoon and secondary structure that tag and ASPE Auele Specific Primer fragment may form, on 8 kinds of microballoons numberings of selection and microballoon, corresponding anti-tag sequence is as shown in table 2:
Corresponding anti-tag sequence on table 2 microballoon numbering and microballoon
8 kinds of microballoons selecting, purchased from Luminex company of the U.S., are coated in anti-tag sequence on microballoon.Between anti-tag sequence and microballoon, be connected with the spacerarm sequence of 5-10 T, before each anti-tag sequence, add the spacerarm sequence of the preceding paragraph 5-10 T, anti-tag sequence is synthesized by Shanghai Sangon Biological Engineering Technology And Service Co., Ltd.By synthetic anti-tag sequence sterilizing ddH
2o is made into the stock solution of 100nmol/ml.Described spacerarm is for by anti-tag and microsphere surface is spaced apart or anti-tag is placed in to the sequence of hydrophilic environments.By the spacerarm sequence of suitable length is set between anti-tag sequence and microballoon, can reduce sterically hinderedly, improve the efficiency of hybridization and the specificity of hybridization.Common spacerarm sequence comprises poly dT, i.e. poly (dT), and oligomerization four polyoxyethylene glycol and (CH2) n spacerarm (n >=3), as (CH2) 12, (CH2) 18 etc.In addition, if exist poly (dA) to disturb, can also use poly (TTG) as spacerarm.Spacerarm of the present invention is preferably 5-10 T, and the coated process of microballoon is as follows:
Get respectively 5 × 10
6the carboxylated microballoon (purchased from Luminex company) of individual above-mentioned numbering is suspended in the MES solution of 50ul 0.1mol/L (pH4.5), adds the synthetic anti-tag molecule (100nmol/ml) of 10ul.EDC (N-(3-Dimethylaminopropyl-N-ethylcarbodiimide) (purchased from the Pierce Chemical company) working fluid of preparation 10ng/ml.Toward the EDC working fluid that adds 2.5ul in microballoon suspension, constant-temperature incubation 30 minutes, then add the EDC working fluid of 2.5ul, then constant-temperature incubation 30 minutes.After reaction finishes, the Tween-20 with 0.02% washs once, then washs once with 0.1% SDS liquid.The Tris-EDTA solution [10mmol/L Tris (pH8.0)] that the microballoon that is coated with anti-tag sequence after washing is resuspended in to 100ul, in 1mmol/LEDTA, 2-8 ℃ keeps in Dark Place.
Three, amplify the primer of the target sequence that contains mutational site
For MEK1 gene four kinds of common genotype Q56P, K57N, D67N and P124L, design of amplification primers, to (in table 3), amplifies 2 target sequences that contain 4 mutational sites, and wherein, Q56P, K57N and D67N are positioned at same amplified production.
Table 3 amplifies the primer of the target sequence with mutational site
All primers are synthesized by Shanghai Sangon Biological Engineering Technology And Service Co., Ltd.Every primer after synthetic is mixed with respectively the stock solution of 100pmol/mL with 10mmol/L Tris Buffer.
Embodiment 2 uses the detection to sample of MEK1 gene mutation detection liquid-phase chip described in embodiment 1
The formula of described various solution is as follows:
MES damping fluid (pH5.0) formula (250ml) of 50mM:
2 × Tm hybridization buffer
| Reagent | Source | Final concentration | The consumption of every 250ml |
| 1MTris-HCl，pH8.0 | Sigma T3038 | 0.2M | 50ml |
| 5M NaCl | Sigma S5150 | 0.4M | 20ml |
| Triton X-100 | Sigma T8787 | 0.16％ | 0.4ml |
After filtration, be stored in 4 ℃.
ExoSAP-IT test kit is purchased from USB company of the U.S..
Biotin labeled dCTP is purchased from Shanghai Sangon Biological Engineering Technology And Service Co., Ltd.
One, the DNA extraction of sample:
Methods involving with reference to " molecular cloning " about DNA extraction, obtains DNA to be detected.
Two, the pcr amplification of testing sample
Design 2 pairs of primers, multiplex PCR one step amplifies 2 respectively containing the target sequence of Q56P, K57N, D67N and P124L, and wherein, Q56P, K57N and D67N are positioned at same amplified production.Product size is respectively 289bp and 245bp, and primer sequence (SEQ ID NO.25-28) is shown in shown in above-mentioned table 3.
First prepare multiple PCR primer working fluid: respectively get respectively the primer stock solution 100ul of SEQ ID NO.25-28 in 1.5ml Eppendorf tube, mix and be multiple PCR primer working fluid.Multi-PRC reaction system is as follows:
Pcr amplification program is: 95 ℃ of 3min; 94 ℃ of 30s, 56 ℃ of 30s, 72 ℃ of 40s, 30 circulations; 72 ℃ of 10min; 4 ℃ save backup.
Three, the enzyme of PCR product is cut processing
1. get the reacted product of 7.5ul PCR, add 1ul 10 × SAP damping fluid, 1ul SAP enzyme and 0.5ul Exo-I enzyme;
2. hatch 15min for 37 ℃, hatch 15min for 80 ℃, the enzyme that deactivation is unnecessary.Enzyme is cut product after treatment and is directly used in follow-up ASPE primer extension reaction.
Four, site-specific primer extension reaction (ASPE)
Utilize the ASPE primer of above-mentioned design to carry out primer extension reaction, in reaction process, mix biotin labeled dCTP, thereby make multiple biotin labeling on reacted product band.
First the ASPE primer working fluid that preparation mixes: get respectively the corresponding wild-type of gene to be detected and saltant type ASPE primer stock solution 10ul in 1.5ml Eppendorf tube, add 10mmol/L Tris Buffer to mend to 200ul, mix and be ASPE mix primer working fluid.The system of ASPE reaction is as follows:
Response procedures is: 96 ℃ of 2min; 94 ℃ of 30s, 54 ℃ of 1min, 72 ℃ of 2min, 30 circulations; 4 ℃ save backup.
Five, hybridization
1. according to the ASPE primer of design, every group selection is coated microballoon (as described in Example 1) accordingly, and every kind of microballoon concentration is 2.5 × 10
5individual/ml;
2. get respectively the microballoon of every kind of numbering of 1ul in the Eppendorf tube of 1.5ml;
3. microballoon is in >=centrifugal the 1-2min of 10000g;
4. supernatant discarded, microballoon is resuspended in 2 × Tm hybridization buffer of 100ul, and vortex mixes;
5. get the above-mentioned microballoon suspension of 25ul in the 96 corresponding holes of hole filter plate, control wells adds the ddH of 25ul
2o;
6. get the ASPE reaction solution of 5-25ul in corresponding hole, use ddH
2o complements to 50ul;
7. encase 96 orifice plates with lucifuge with masking foil, 95 ℃ of 60s, 37 ℃ of 15min are hatched hybridization;
8. the microballoon after hybridization is in >=centrifugal the 2-5min of 3000g;
9. remove supernatant, microballoon is resuspended in 1 × Tm hybridization buffer of 75ul;
10. microballoon is in >=centrifugal the 2-5min of 3000g;
11. are resuspended in microballoon in 1 × Tm hybridization buffer of 75ul, and adding 15ul concentration is the SA-PE (SA-PE) of 10ug/ml;
Hatch 15min for 12.37 ℃, on Luminex instrument, detect.
Six, result detects and data analysis
Reaction after product detects by Luminex serial analysis instrument.Be greater than 100 as cut-off values take saltant type fluorescent value (MFI), in the time that the MFI value of saltant type detection is greater than 100, judges that this sample exists this mutation type, otherwise judge that this sample is as corresponding wild-type.
Use present method to detect the MEK1 transgenation of great amount of samples, detect with liquid-phase chip result and compare with sequencing, calculate the identical rate of method detected result provided by the present invention.Present method detects 20 increments MEK1 genotype detection result and the sequencing result rate of coincideing originally and reaches 100%.Visible MEK1 gene mutation detection liquid-phase chip provided by the present invention can detect the mutation type of MEK1 gene exactly, and result is reliable and stable.
One of table 4 pattern detection result (MFI)
Table 5 sample MEK1 gene mutation type analytical results
| Catalogue number(Cat.No.) | Liquid-phase chip detected result | Sequencing result |
| 1 | Wild-type | Wild-type |
| 2 | Wild-type | Wild-type |
| 3 | Wild-type | Wild-type |
| 4 | Wild-type | Wild-type |
| 5 | Q56P sudden change | Q56P sudden change |
| 6 | Wild-type | Wild-type |
| 7 | Wild-type | Wild-type |
| 8 | P124L sudden change | P124L sudden change |
| 9 | Wild-type | Wild-type |
| 10 | Wild-type | Wild-type |
| 11 | K57N sudden change | K57N sudden change |
| 12 | Wild-type | Wild-type |
| 13 | Wild-type | Wild-type |
| 14 | Wild-type | Wild-type |
| 15 | D67N sudden change | D67N sudden change |
| 16 | Wild-type | Wild-type |
| 17 | Wild-type | Wild-type |
| 18 | Wild-type | Wild-type |
| 19 | Wild-type | Wild-type |
| 20 | Wild-type | Wild-type |
The detection of the liquid-phase chip of the ASPE primer that embodiment 3 is different to MEK1 gene mutation site
One, the design (selection of tag sequence and Anti-tag sequence) that prepared by liquid-phase chip
Detect liquid-phase chip as example take MEK1 gene Q56P and D67N site mutation, respectively for the wild-type of Q56P and D67N and the specific primer sequence of saltant type design ASPE primer 3 ' end, the tag sequence of ASPE primer 5 ' end is selected from SEQ ID NO.1-SEQ ID NO.8, accordingly, the anti-tag sequence with corresponding tag sequence complementary pairing being coated on microballoon is selected from SEQ ID NO.17-SEQ ID NO.24.Specific design is as shown in following table (table 6).Synthetic, the anti-tag sequence of ASPE primer are coated with microballoon, amplimer, detection method etc. as described in embodiment 1 and embodiment 2.
Design prepared by table 6 liquid-phase chip
Two, sample detection
The liquid-phase chip that adopts above-mentioned design to prepare, detects sample 21-40 by testing process described in embodiment 2 and method, and detected result is as follows:
Table 7 pattern detection result and gene mutation analysis
Table 8 pattern detection result and gene mutation analysis
Other is for the liquid-phase chip in different mutational sites, and ASPE primer uses different tag sequences, and its result is still reliable and stable, and concrete data are omitted.And ASPE primer is while selecting in embodiment 1 collocation of tag sequence and specific primer sequence, effect better (signal to noise ratio is better), referring to the present embodiment test group 1 and test group 5.Other different tag sequences and specific primer sequence collocation, with coming to the same thing of embodiment 2 and the present embodiment, concrete data are omitted.
The selection of embodiment 4 MEK1 detection in Gene Mutation specific primer sequences
One, the design (selection of wild-type and saltant type specific primer sequence) that prepared by liquid-phase chip
Detect liquid-phase chip as example take the mutational site of MEK1 gene K57N and P124L, take the complementary sequence forward or backwards of this place, mutational site target sequence as template, respectively for the wild-type of K57N and P124L and the specific primer sequence of saltant type design ASPE primer 3 ' end, comprise preferred specific primer sequence and 2 alternative specific primer sequences in the embodiment of the present invention 1, as shown in table 9.Wherein,
interior base is mutational site.
Table 9 specific primer sequence
Detect liquid-phase chip as example take the mutational site of MEK1 gene K57N and P124L, select different specific primer sequences for K57N and P124L, the tag sequence of ASPE primer 5 ' end is fixed as the best effect sequence in embodiment 1, and select the anti-tag sequence of answering in contrast, specific design is as shown in following table (table 10).Synthetic, the anti-tag sequence of ASPE primer are coated with microballoon, amplimer, detection method etc. as described in embodiment 1 and embodiment 2.
Two of design prepared by table 10 liquid-phase chip
Two, sample detection
The liquid-phase chip that adopts above-mentioned design to prepare, detects sample 41-60 by testing process described in embodiment 2 and method, and detected result is as follows:
Table 11 pattern detection result and gene mutation analysis
Table 12 pattern detection result and gene mutation analysis
From the present embodiment, when ASPE primer is selected in embodiment 1 collocation of specific primer sequence and tag sequence, effect better (signal to noise ratio is better), referring to the present embodiment test group 7 and test group 10.Other derives from different specific primer sequences and the collocation of tag sequence of the complementary sequence forward or backwards of place, target detect site sequence, with coming to the same thing of embodiment 2 and the present embodiment, be still that the specific primer sequence described in embodiment 1 is better from different tag sequence arranging effects, concrete data are omitted.
Other multiple specific primer sequence for different mutational sites and the collocation of tag sequence, with coming to the same thing of embodiment 2 and the present embodiment, the selected Auele Specific Primer of embodiment 1, has better signal to noise ratio, detect effect also better, concrete data are omitted.
Be more than for the illustrating of possible embodiments of the present invention, but this embodiment is not in order to limit the scope of the claims of the present invention, allly do not depart from the equivalence that skill spirit of the present invention does and implement or change, all should be contained in the scope of the claims of the present invention.
Claims (5)
1. a MEK1 gene mutation detection liquid-phase chip, is characterized in that, includes:
(A). the wild-type designing respectively for the different mutational sites of MEK1 gene and the ASPE primer of saltant type: every kind of ASPE primer is made up of for the specific primer sequence in goal gene mutational site tag sequence and the 3 ' end of 5 ' end, and described specific primer sequence is: for SEQ ID NO.9 and the SEQ ID NO.10 in Q56P site; For SEQ ID NO.11 and the SEQ ID NO.12 in K57N site; For SEQ ID NO.13 and the SEQ ID NO.14 in D67N site; And/or for SEQ ID NO.15 and the SEQ ID NO.16 in P124L site; Described tag sequence is selected from SEQ ID NO.1～SEQ ID NO.8;
(B). there is microballoon that anti-tag sequence is coated with, that there is different colours coding, in the middle of described anti-tag sequence is connected with microballoon, be also provided with spacerarm sequence; Described anti-tag sequence is selected from SEQ ID NO.17～SEQ ID NO.24, and described anti-tag sequence can be correspondingly with (A) in selected tag sequence complementary pairing;
(C). for amplifying the primer that needs the target sequence detecting, have corresponding mutational site, described amplimer is: for SEQ ID NO.25 and the SEQ ID NO.26 in Q56P, K57N, D67N site; And/or for SEQ ID NO.27 and the SEQ ID NO.28 in P124L site.
2. MEK1 gene mutation detection liquid-phase chip according to claim 1, it is characterized in that, described ASPE primer is: for the sequence being made up of SEQ ID NO.1 and SEQ ID NO.9 in Q56P site and the sequence that is made up of SEQ ID NO.2 and SEQ ID NO.10; For the sequence being formed by SEQ ID NO.3 and SEQ ID NO.11 in K57N site and the sequence that formed by SEQ ID NO.4 and SEQ ID NO.12; For the sequence being formed by SEQ ID NO.5 and SEQ ID NO.13 in D67N site and the sequence that formed by SEQ ID NO.6 and SEQ ID NO.14; And/or for the sequence being formed by SEQ ID NO.7 and SEQ ID NO.15 in P124L site and the sequence that formed by SEQ ID NO.8 and SEQ ID NO.16.
3. MEK1 gene mutation detection liquid-phase chip according to claim 1, is characterized in that,
(A). described ASPE primer is: for the sequence being made up of SEQ ID NO.1 and SEQ ID NO.9 in Q56P site and the sequence that is made up of SEQ ID NO.2 and SEQ ID NO.10; For the sequence being formed by SEQ ID NO.3 and SEQ ID NO.11 in K57N site and the sequence that formed by SEQ ID NO.4 and SEQ ID NO.12; For the sequence being formed by SEQ ID NO.5 and SEQ ID NO.13 in D67N site and the sequence that formed by SEQ ID NO.6 and SEQ ID NO.14; With the sequence being formed by SEQ ID NO.7 and SEQ ID NO.15 for P124L site and the sequence being formed by SEQ ID NO.8 and SEQ ID NO.16;
(B). there is microballoon that anti-tag sequence is coated with, that there is different colours coding, in the middle of described anti-tag sequence is connected with microballoon, be also provided with spacerarm sequence; Described anti-tag sequence is selected from SEQ ID NO.17～SEQ ID NO.24, and described anti-tag sequence can be correspondingly with (A) in selected tag sequence complementary pairing;
(C). described amplimer is: for SEQ ID NO.25 and the SEQ ID NO.26 in Q56P, K57N, D67N site; With SEQ ID NO.27 and the SEQ ID NO.28 for P124L site.
4. according to the MEK1 gene mutation detection liquid-phase chip described in claim 1-3 any one, it is characterized in that, described spacerarm is 5-10 T.
5. for the Auele Specific Primer of MEK1 detection in Gene Mutation, it is characterized in that, described Auele Specific Primer is: for SEQ ID NO.9 and the SEQ ID NO.10 in Q56P site; For SEQ ID NO.11 and the SEQ ID NO.12 in K57N site; For SEQ ID NO.13 and the SEQ ID NO.14 in D67N site; And/or for SEQ ID NO.15 and the SEQ ID NO.16 in P124L site.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110269701.1A CN102994616B (en) | 2011-09-13 | 2011-09-13 | MEK1 gene mutation detection specificity primer and liquid chip thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110269701.1A CN102994616B (en) | 2011-09-13 | 2011-09-13 | MEK1 gene mutation detection specificity primer and liquid chip thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102994616A CN102994616A (en) | 2013-03-27 |
| CN102994616B true CN102994616B (en) | 2014-06-18 |
Family
ID=47923722
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201110269701.1A Active CN102994616B (en) | 2011-09-13 | 2011-09-13 | MEK1 gene mutation detection specificity primer and liquid chip thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102994616B (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007057399A2 (en) * | 2005-11-15 | 2007-05-24 | Boehringer Ingelheim International Gmbh | Treatment of cancer with indole derivatives |
| CN101781684A (en) * | 2010-01-29 | 2010-07-21 | 广州益善生物技术有限公司 | Liquid phase chip for CYP19A1 gene SNP (Single Nucleotide Polymorphism) detection and detection method thereof |
-
2011
- 2011-09-13 CN CN201110269701.1A patent/CN102994616B/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007057399A2 (en) * | 2005-11-15 | 2007-05-24 | Boehringer Ingelheim International Gmbh | Treatment of cancer with indole derivatives |
| CN101781684A (en) * | 2010-01-29 | 2010-07-21 | 广州益善生物技术有限公司 | Liquid phase chip for CYP19A1 gene SNP (Single Nucleotide Polymorphism) detection and detection method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102994616A (en) | 2013-03-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102994619B (en) | NRAS gene mutation detection specificity primer and liquid chip thereof | |
| CN102994617B (en) | HRAS gene mutation detection specificity primer and liquid chip thereof | |
| CN102994621B (en) | PTPN11 gene mutation detection specificity primer and liquid chip thereof | |
| CN103031370B (en) | RB1 gene mutation detection specific primer and liquid chip | |
| CN102912002B (en) | ABCB2 gene polymorphism detection specific primers and liquid chip | |
| CN103031365B (en) | ATM gene mutation detection specific primer and liquid chip | |
| CN103031369B (en) | CDKN2A gene mutation detection specific primer and liquid chip | |
| CN102994616B (en) | MEK1 gene mutation detection specificity primer and liquid chip thereof | |
| CN103374607B (en) | ABCC (ATP (adenosine triphosphate)-binding cassette, sub-family C)1 gene mutation detection specific primers and liquid chip | |
| CN102952866B (en) | Specific primer and liquid chip for detecting polymorphism of DPYD (dihydropyrimidine dehydrogenase) gene | |
| CN103031364B (en) | FGFR3 gene mutation detection specific primer and liquid chip | |
| CN102994620B (en) | AKT1 gene mutation detection specificity primer and liquid chip thereof | |
| CN102191336B (en) | MYC gene single nucleotide polymorphism (SNP) detection specific primer and liquid-phase chip | |
| CN102994625B (en) | PIK3R1 gene mutation detection specificity primer and liquid chip thereof | |
| CN103031367A (en) | VHL (Von Hippel Lindau) genetic mutation detection specific primer and liquid phase chip | |
| CN103031368B (en) | FGFR1 gene mutation detection specific primer and liquid chip | |
| CN102912005B (en) | CYP2C8 gene polymorphism detection specific primers and liquid chip | |
| CN103031371B (en) | CDH1 gene mutation detection specific primer and liquid chip | |
| CN102994623B (en) | STK11 gene mutation detection specificity primer and liquid chip thereof | |
| CN103031366B (en) | FGFR2 gene mutation detection specific primer and liquid chip | |
| CN102191335B (en) | Specific primer and liquid-phase chip for SNP (single nucleotide polymorphism) detection of PIGU (phosphatidylinositol glycan anchor biosynthesis, class U) genes | |
| CN102994618B (en) | AKT3 gene mutation detection specificity primer and liquid chip thereof | |
| CN102888444B (en) | Factor II and Factor V genetic polymorphism detection specific primer and liquid-phase chip | |
| CN103571920A (en) | Specific detection primers and detection liquid phase chip for KLK3 gene mutation | |
| CN102912007B (en) | CYP2B6 gene polymorphism detection specific primers and liquid chip |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C53 | Correction of patent for invention or patent application | ||
| CB02 | Change of applicant information |
Address after: Five 510663 Guangdong city of Guangzhou province Guangzhou Science City Moon Road No. 80, Guangzhou technology innovation base B, C Applicant after: Surexam Biological Technology Co., Ltd. Address before: Five 510663 Guangdong city of Guangzhou province Guangzhou Science City Moon Road No. 80, Guangzhou technology innovation base B, C Applicant before: Guangzhou Yishan Biotechnology Co., Ltd. |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: GUANGZHOU YISHAN BIOTECHNOLOGY CO., LTD. TO: SUREXAM BIOTECHNOLOGY CO., LTD. |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |